黒い菌の後, India reports new complication in Covid patients – ライブフォロー

黒い菌の後, India reports new complication in Covid patients - ライブフォロー

<p>ファイル: Covid-19 patients are being treated inside an intensive care unit of a hospital in Delhi on 28 五月p 2021</p><p>ファイル: Covid-19 patients are being treated inside an intensive care unit of a hospital in Delhi on 28 五月p 2021</p>

ファイル: Covid-19 patients are being treated inside an intensive care unit of a hospital in Delhi on 28 五月, 2021

Even as India continues to grapple with black fungus infections among COVID-19 患者, a hospital in the national capital デリー has reported cases of another post-コロナウイルス 合併症.

Sir Ganga Ram Hospital has reported five cases of Cytomegalovirus-related rectal bleeding in patients who had earlier tested positive for Covid-19. One of them died due to “massive bleeding and severe Covid chest disease,” the hospital said.

Dr Anil Arora from the hospital was quoted as saying in media reports that the patients presented with symptoms like abdominal pain and bleeding in stools an average of 20 に 30 days after their first Covid diagnosis.

He said that Cytomegalovirus exists in the body in an asymptomatic form, but symptoms are seen when a person’s immunity is compromised, 通信社PTIによると. Covid-19 and the medicines used in its treatment affect immunity, making a person more susceptible to other infections, 彼は言った.

その間, the developers of Russia’s Sputnik V vaccine have said that the shot is 90 per cent effective against the Delta variant of Covid-19, これはインドで最初に検出されました.


Indian vaccine effective against Delta variant, says US health institute

The US’ National Institute of Health has said that India’s homegrown Covid-19 vaccine ‘Covaxin’ — made by Bharat Biotech — effectively neutralises both Alpha and Delta variants of coronavirus.

Alpha variant was first identified in the UK and Delta was detected in India.

Bharat Biotech last week had a pre-submission meeting with the World Health Organisation for emergency use listing of Covaxin.

アクシタジャイン30 六月 2021 07:06

Indian minister takes up Covishield authorisation with EU

India’s external affairs minister S Jaishankar said he has raised the matter of authorisation of Covishield — the Oxford-AstraZeneca shot made by Serum Institute of India — for travel to the EU.

He discussed it during a meeting with Josep Borell Fontelles, high representative of the EU for foreign affairs and security policy, on the sidelines of the G20 ministerial meetings.

This comes amid reports that Indians inoculated with Covishield may not be eligible for EU’s green pass because it’s not one of the vaccines approved by the European Medicines Agency.

しかしながら, ambassador of the European Union to India and Bhutan Ugo Astuto has said that green pass is not a precondition to travel and states can choose to accept vaccines approve by the World Health Organisation.

アクシタジャイン30 六月 2021 06:40

Brazil to suspend deal to buy Indian vaccine

Brazil will temporarily suspend a deal to buy India’s indigenous Covid-19 vaccine Covaxin — made by Bharat Biotech — after allegations of irregularities in the contract.

Brazil’s health ministry said in a statement that the preliminary analysis of federal comptroller CGU found no irregularities, but the suspension decision follows compliance practices and won’t affect the vaccination drive in the country.

Brazilian federal prosecutors are investigating the deal. President Jair Bolsonaro has denied being aware of any irregularities.

アクシタジャイン30 六月 2021 06:17

India says 49% people over 60 vaccinated with first dose

The Indian government has said that 49 per cent of its population over the age of 60 years has been vaccinated with at least one dose of Covid-19 vaccine.

The country launched its vaccination drive on 16 January and has only fully inoculated about 5 per cent of its population so far. It began vaccinating people aged 60 or above from 1 行進.

India is looking to ramp up its vaccination drive to reach its goal of inoculating the entire adult population by the end of December.

アクシタジャイン30 六月 2021 05:55

おはようございます, へようこそ インデペンデント coverage of the coronavirus pandemic for Wednesday 30 六月, 2021.

アクシタジャイン30 六月 2021 05:11